Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.
2.

Treatment perspectives in advanced non-small cell lung cancer.

Soto Parra H, Latteri F, Cavina R, Sala A, Dambrosio M, Alloisio M, Santoro A.

Tumori. 2000 Sep-Oct;86(5 Suppl 1):S36-41. Review. No abstract available.

PMID:
11195292
3.

Chemotherapy for lung cancer: the state of the art in 2009.

Higgins MJ, Ettinger DS.

Expert Rev Anticancer Ther. 2009 Oct;9(10):1365-78. doi: 10.1586/era.09.115. Review.

PMID:
19827996
4.

Therapeutic options for elderly patients with advanced non-small cell lung cancer.

Avery EJ, Kessinger A, Ganti AK.

Cancer Treat Rev. 2009 Jun;35(4):340-4. doi: 10.1016/j.ctrv.2008.10.008. Epub 2009 Jan 19. Review.

PMID:
19155139
5.

Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue.

Petrelli F, Ghilardi M, Cremonesi M, Cabiddu M, Barni S.

Expert Rev Anticancer Ther. 2009 Oct;9(10):1455-65. doi: 10.1586/era.09.112. Review.

PMID:
19828007
6.
7.

Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.

Bunn PA Jr, Thatcher N.

Oncologist. 2008;13 Suppl 1:37-46. doi: 10.1634/theoncologist.13-S1-37. Review.

8.

Best supportive care versus palliative chemotherapy in nonsmall-cell lung cancer.

Medley L, Cullen M.

Curr Opin Oncol. 2002 Jul;14(4):384-8. Review.

PMID:
12130920
9.

[Chemotherapy for advanced non-small-cell lung cancer: combinations without platinium derivatives].

Pujol JL.

Rev Pneumol Clin. 2004 Nov;60(5 Pt 3):4S17-4S19. Review. French. No abstract available.

PMID:
15687988
10.

Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?

Ruckdeschel JC, Gridelli C, Perrone F, Monfardini S, Giaccone G.

Eur J Cancer. 1998 Dec;34(13):1993-9. Review. No abstract available.

PMID:
10070300
11.

[Second-line chemotherapy in non-small-cell lung cancer].

Schütte W.

Rev Pneumol Clin. 2004 Nov;60(5 Pt 3):4S13-4S16. Review. French. No abstract available.

PMID:
15687987
12.

Complexities of quality of life analysis in non-small cell lung cancer.

Temel J.

J Support Oncol. 2007 Jan;5(1):30-1. Review. No abstract available.

PMID:
17265784
13.

Overview of non-small cell lung cancer.

Flood WA.

Manag Care. 2005 Feb;14(2 Suppl):4-8. Review. No abstract available.

14.

[The status and prospects of treatment protocols for elderly patients with non-small cell lung cancer].

Zhou J, Gao B.

Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):598-605. doi: 10.3779/j.issn.1009-3419.2011.07.07. Review. Chinese.

15.

[Recent progress for chemotherapy in advanced non-small cell lung cancer].

Takahashi K.

Nihon Naika Gakkai Zasshi. 2011 Mar 10;100(3):763-71. Review. Japanese. No abstract available.

PMID:
21618810
16.

Lung cancer: epidemiology and chemotherapy of advanced disease: the Hong Kong perspective.

Lam WK, Ip MS.

J Med Assoc Thai. 1991 Aug;74(8):341-51. Review. No abstract available.

PMID:
1791384
17.

Targeted therapy vs chemotherapy: which has had more impact on survival in lung cancer? The significant impact of chemotherapy in lung cancer.

Socinski MA.

Clin Adv Hematol Oncol. 2014 Nov;12(11):763, 767-8. Review. No abstract available.

PMID:
25674716
18.

[Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 7. Lung cancer treatment in elderly and/or high risk patients].

Kimura T, Kudoh S, Hirata K.

Nihon Naika Gakkai Zasshi. 2014 Jun 10;103(6):1346-54. Review. Japanese. No abstract available.

PMID:
25151800

Supplemental Content

Support Center